Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000414036 | SCV000490820 | likely pathogenic | not provided | 2015-08-11 | criteria provided, single submitter | clinical testing | The L521R variant has not been published as a pathogenic variant, nor has it been reported as a benignpolymorphism to our knowledge. The L521R variant is a non-conservative amino acid substitution, which islikely to impact secondary protein structure as these residues differ in polarity, charge, size and/or otherproperties. This substitution occurs at a position where amino acids with similar properties to Leucine aretolerated across species. In silico analysis predicts this variant is probably damaging to the proteinstructure/function. Furthermore, missense variants in nearby residues (H516Q, E517V, Y519C, N522S,Q525H) have been reported in the Human Gene Mutation Database in association with Niemann-Pick disease(Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, thisvariant is a strong candidate for a pathogenic variant, however the possibility that it is a benign variantcannot be excluded. |
Breakthrough Genomics, |
RCV004596176 | SCV005088893 | likely pathogenic | Niemann-Pick disease, type A | 2021-03-30 | criteria provided, single submitter | clinical testing | This variant is predicted to be damaging by in-silico missense prediction tools (SIFT and Polyphen2). The variant has not been previously reported in individuals with SMPD1-related disorders. However, several other missense variants in the vicinity of identified variant have been previously reported as ‘likely pathogenic’ in the context of Niemann-Pick disease, type A and type B in ClinVar database. |